NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Taiwan Semiconductor
TSM
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
BTAI BioXcel Therapeutics
- 2.700
- -1.050-28.00%
Close Mar 4 16:00 ET
- 2.790
- +0.090+3.33%
Post 20:01 ET
8.37MMarket Cap-0.08P/E (TTM)
3.500High2.520Low2.28MVolume3.500Open3.750Pre Close6.63MTurnover100.25%Turnover RatioLossP/E (Static)3.10MShares52.80052wk High-0.10P/B6.15MFloat Cap1.72052wk Low--Dividend TTM2.28MShs Float1144.000Historical High--Div YieldTTM26.13%Amplitude1.720Historical Low2.899Avg Price1Lot Size
BioXcel Therapeutics Stock Forum
BioXcel Therapeutics Announces Closing of $14 Million Registered Direct Offering
Tuesday, 4th March at 4:15 pm
NEW HAVEN, Conn., March 04, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company") (NASDAQ: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced the closing of its previously announced registered direct offering of 4,000,000 shares (the "Shares") of commo...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...
BioXcel Therapeutics Announces $14 Million Registered Direct Offering
Monday, 3rd March at 3:33 pm
NEW HAVEN, Conn., March 03, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company") (NASDAQ: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale in...
No comment yet